We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .